Literature DB >> 26686676

Study of a fetal brain affected by a severe form of tyrosine hydroxylase deficiency, a rare cause of early parkinsonism.

Alba Tristán-Noguero1,2, Héctor Díez1,2, Cristina Jou3, Mercè Pineda2,4, Aida Ormazábal5,4, Aurora Sánchez4,6, Rafael Artuch5,4, Àngels Garcia-Cazorla7,8,9.   

Abstract

Tyrosine hydroxylase (TH) deficiency is an inborn error of dopamine synthesis. Two clinical phenotypes have been described. The THD "B" phenotype produces a severe encephalopathy of early-onset with sub-optimal L-Dopa response, whereas the "A" phenotype has a better L-Dopa response and outcome. The objective of the study is to describe the expression of key synaptic proteins and neurodevelopmental markers in a fetal brain of THD "B" phenotype. The brain of a 16-week-old miscarried human fetus was dissected in different brain areas and frozen until the analysis. TH gene study revealed the p.R328W/p.T399M mutations, the same mutations that produced a B phenotype in her sister. After protein extraction, western blot analyses were performed to assess protein expression. The results were compared to an age-matched control. We observed a decreased expression in TH and in other dopaminergic proteins, such as VMAT 1 and 2 and dopamine receptors, especially D2DR. GABAergic and glutamatergic proteins such as GABA VT, NMDAR1 and calbindin were also altered. Developmental markers for synapses, axons and dendrites were decreased whereas markers of neuronal volume were preserved. Although this is an isolated case, this brain sample is unique and corresponds to the first reported study of a THD brain. It provides interesting information about the influence of dopamine as a regulator of other neurotransmitter systems, brain development and movement disorders with origin at the embryological state. This study could also contribute to a better understanding of the pathophysiology of THD at early fetal stages.

Entities:  

Keywords:  Human fetal brain; Infantile parkinsonism; Neurodevelopmental markers; Neurotransmitter systems markers; Tyrosine hydroxylase deficiency

Mesh:

Substances:

Year:  2015        PMID: 26686676     DOI: 10.1007/s11011-015-9780-z

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  15 in total

1.  Brain catecholamine depletion and motor impairment in a Th knock-in mouse with type B tyrosine hydroxylase deficiency.

Authors:  Germaine Korner; Daniela Noain; Ming Ying; Magnus Hole; Marte I Flydal; Tanja Scherer; Gabriella Allegri; Anahita Rassi; Ralph Fingerhut; Damasia Becu-Villalobos; Samyuktha Pillai; Stephan Wueest; Daniel Konrad; Anna Lauber-Biason; Christian R Baumann; Laurence A Bindoff; Aurora Martinez; Beat Thöny
Journal:  Brain       Date:  2015-08-14       Impact factor: 13.501

Review 2.  Neuroanatomical phenotyping in the mouse: the dopaminergic system.

Authors:  C J Zeiss
Journal:  Vet Pathol       Date:  2005-11       Impact factor: 2.221

3.  Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis.

Authors:  Michèl A Willemsen; Marcel M Verbeek; Erik-Jan Kamsteeg; Johanneke F de Rijk-van Andel; Alec Aeby; Nenad Blau; Alberto Burlina; Maria A Donati; Ben Geurtz; Padraic J Grattan-Smith; Martin Haeussler; Georg F Hoffmann; Hans Jung; Johannis B de Klerk; Marjo S van der Knaap; Fernando Kok; Vincenzo Leuzzi; Pascale de Lonlay; Andre Megarbane; Hugh Monaghan; Willy O Renier; Pierre Rondot; Monique M Ryan; Jürgen Seeger; Jan A Smeitink; Gerry C Steenbergen-Spanjers; Evangeline Wassmer; Bernhard Weschke; Frits A Wijburg; Bridget Wilcken; Dimitrios I Zafeiriou; Ron A Wevers
Journal:  Brain       Date:  2010-04-29       Impact factor: 13.501

Review 4.  Functions of the nigrostriatal dopaminergic synapse and the use of neurotransplantation in Parkinson's disease.

Authors:  Alex Tsui; Ole Isacson
Journal:  J Neurol       Date:  2011-05-05       Impact factor: 4.849

5.  Compensatory regulation of dopamine after ablation of the tyrosine hydroxylase gene in the nigrostriatal projection.

Authors:  Hirofumi Tokuoka; Shin-ichi Muramatsu; Chiho Sumi-Ichinose; Hiroaki Sakane; Masayo Kojima; Yoshinori Aso; Takahide Nomura; Daniel Metzger; Hiroshi Ichinose
Journal:  J Biol Chem       Date:  2011-10-25       Impact factor: 5.157

6.  Targeted disruption of the tyrosine hydroxylase locus results in severe catecholamine depletion and perinatal lethality in mice.

Authors:  K Kobayashi; S Morita; H Sawada; T Mizuguchi; K Yamada; I Nagatsu; T Hata; Y Watanabe; K Fujita; T Nagatsu
Journal:  J Biol Chem       Date:  1995-11-10       Impact factor: 5.157

7.  Targeted disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse fetal development.

Authors:  Q Y Zhou; C J Quaife; R D Palmiter
Journal:  Nature       Date:  1995-04-13       Impact factor: 49.962

8.  Dopamine receptors in human embryonic stem cell neurodifferentiation.

Authors:  Glenn S Belinsky; Carissa L Sirois; Matthew T Rich; Shaina M Short; Anna R Moore; Sarah E Gilbert; Srdjan D Antic
Journal:  Stem Cells Dev       Date:  2013-02-19       Impact factor: 3.272

Review 9.  Striatal plasticity in Parkinson's disease and L-dopa induced dyskinesia.

Authors:  M M Iravani; A C McCreary; P Jenner
Journal:  Parkinsonism Relat Disord       Date:  2012-01       Impact factor: 4.891

Review 10.  Developmental origins of brain disorders: roles for dopamine.

Authors:  Kelli M Money; Gregg D Stanwood
Journal:  Front Cell Neurosci       Date:  2013-12-19       Impact factor: 5.505

View more
  1 in total

Review 1.  Dopa-responsive dystonia caused by tyrosine hydroxylase deficiency: Three cases report and literature review.

Authors:  Han-Yu Dong; Jun-Yan Feng; Xiao-Jing Yue; Ling Shan; Fei-Yong Jia
Journal:  Medicine (Baltimore)       Date:  2020-08-14       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.